279 related articles for article (PubMed ID: 9017770)
21. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
22. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
Clin Ther; 1993; 15(2):364-73. PubMed ID: 8519044
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of enalapril versus extended-release nifedipine for the treatment of mild-to-moderate essential hypertension: a multicenter 22-week study. Multicenter Cooperative Study Group.
Leon AS
Clin Ther; 1993; 15(6):1094-107. PubMed ID: 8111807
[TBL] [Abstract][Full Text] [Related]
24. Comparison of ramipril and enalapril in patients with essential hypertension.
Ruddy MC; Mroczek WJ
Pharmacotherapy; 1993; 13(3):224-8. PubMed ID: 8321736
[TBL] [Abstract][Full Text] [Related]
25. Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Study Group.
Gradman AH; Cutler NR; Davis PJ; Robbins JA; Weiss RJ; Wood BC; Michelson EL
Clin Ther; 1998; 20(3):527-38. PubMed ID: 9663368
[TBL] [Abstract][Full Text] [Related]
26. Comparison of monotherapy with enalapril and atenolol in mild to moderate hypertension. The Canadian Enalapril Study Group.
CMAJ; 1987 Nov; 137(9):803-8. PubMed ID: 2894890
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
Rump LC
Arzneimittelforschung; 2010; 60(3):124-30. PubMed ID: 20422943
[TBL] [Abstract][Full Text] [Related]
28. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
Naidoo DP; Sareli P; Marin F; Aroca-Martinez G; Maritz FJ; Jardim PC; Guerrero AA; Thompson CA; Bero T; Drazka J; Kosmalova V; Dumortier T; Smith RD
Adv Ther; 1999; 16(5):187-99. PubMed ID: 10915394
[TBL] [Abstract][Full Text] [Related]
29. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
[TBL] [Abstract][Full Text] [Related]
30. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of trandolapril in mild to moderate hypertension--a double blind comparative clinical trial with enalapril in Indian population.
Shankar PK; Vidyasagar S; Adiga S; Naidu MU; Usha Rani P; Rao D; Bairy KL; Nair S; Jayaprakash B; Shashikiran U; Mukhyapranaprabhu
Indian J Physiol Pharmacol; 2006; 50(4):421-6. PubMed ID: 17402274
[TBL] [Abstract][Full Text] [Related]
33. [Antihypertensive efficacy and tolerability of diltiazem and enalapril, alone or in combination. DESG. Diltiazem Enalapril Study Group].
Zannad F; Gosse P; Bernard-Fernier MF; de La Garoullaye A
Presse Med; 1994 Oct; 23(29):1335-8. PubMed ID: 7984540
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of enalapril combined with diltiazem ER in patients with stage 3-4 essential hypertension.
Gavras H; Chrysant SG; Niederman AL; Marbury TC; Goldstein R; Conradi E
Clin Exp Hypertens; 1998 Jan; 20(1):41-52. PubMed ID: 9507787
[TBL] [Abstract][Full Text] [Related]
36. The long-term tolerability of enalapril in hypertensive patients with renal impairment.
Keane WF; Polis A; Wolf D; Faison E; Shahinfar S
Nephrol Dial Transplant; 1997; 12 Suppl 2():75-81. PubMed ID: 9269706
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy of force titrated doses of diltiazem extended-release. A placebo controlled study.
Lacourcière Y; Poirier L; Lefebvre J; Burford RG
Am J Hypertens; 1995 Mar; 8(3):282-6. PubMed ID: 7794578
[TBL] [Abstract][Full Text] [Related]
38. Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, Phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension.
Park S; Chung N; Kwon J; Yoon JH; Kim YJ; Han DS; Kim HS
Clin Ther; 2005 Apr; 27(4):441-50. PubMed ID: 15922817
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the tolerance and effectiveness of Diltiazem LP 300 mg in hypertensive patients with chronic renal insufficiency].
Bernadet-Monrozies P; Poilleux E; Suc JM
Ann Cardiol Angeiol (Paris); 1998 Oct; 47(8):589-94. PubMed ID: 9809145
[TBL] [Abstract][Full Text] [Related]
40. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
Chrysant SG; Bakris GL
Am J Hypertens; 2004 Jul; 17(7):590-6. PubMed ID: 15233978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
